I have just read the supplement reporting the proceedings of the September 1992 American Cancer Society National Conference on Cancer Prevention and Early Detection. This is a timely and valuable addition to the literature. I am concerned, however, about the content of the conclusion of Bal and Foe
Preventive strategies for cancer in women
โ Scribed by Diane J. Fink
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 725 KB
- Volume
- 60
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract Arzoxifene is a selective estrogen receptor modulator (SERM) that has been shown to be more potent in preclinical testing than currently available agents. Its effects on clinical outcomes are not known. In a randomized, blinded trial, women aged 60 to 85 years with osteoporosis, defined
## Abstract ## BACKGROUND. Women with Lynch syndrome (hereditary nonpolyposis colorectal cancer) have an increased lifetime risk for endometrial and ovarian cancer. Screening and prophylactic surgery have been recommended as prevention strategies. In this study, the authors estimated the net healt